02.1 Orotate vs carbonate

Lithium orotate vs lithium carbonate: salt, lithium, route

Technical document 02.1 · Reviewed 2026-11-19 · Lithium Orotate

On this page
  1. Two salts, two identities
  2. The lithium figure, dose by dose
  3. Handling, solubility and the finished form
  4. What the label has to say
  5. The route question follows the lithium
  6. When each salt is the question

Lithium orotate carries 4.28% lithium and lithium carbonate 18.78%, so the same lithium figure on a label needs about 4.4 times the orotate mass. That difference drives the fill weight, the capsule count and the label; it does not, on its own, change whether the material may be sold as a food or supplement ingredient in a given market. The salt choice and the route are two separate decisions, and this page keeps them apart.

In one line

Orotate carries 4.3% lithium and carbonate 18.8%, so the same claim needs about 4.4 times the orotate mass; the salt changes the mass and the label, not the route question.

Two salts, two identities

Both materials deliver the same element, which is where the similarity ends. Lithium orotate is the lithium salt of orotic acid, a pyrimidine carboxylic acid with one acidic proton, in a 1:1 ratio. Lithium carbonate is the lithium salt of carbonic acid, two lithium ions to one carbonate, and it is a much smaller molecule with a much higher lithium fraction.

Lithium orotate against lithium carbonate
PropertyLithium orotateLithium carbonate
CAS number5266-20-6554-13-2
FormulaC5H3LiN2O4Li2CO3
Molar massAbout 162.03 g/molAbout 73.89 g/mol
Lithium content4.28% by mass18.78% by mass
AppearanceWhite to off-white powderWhite powder
Water solubilitySlightly soluble; a dispersion is a suspensionDissolves with an alkaline reaction
Behaviour with acidNo gasEffervesces, releasing carbon dioxide
Label nameLithium orotateLithium carbonate

A carbonate is an alkaline solid that reacts with acid, which suits an effervescent system and complicates an acidic one; the orotate barely dissolves, which suits a capsule and complicates a drink.

The lithium figure, dose by dose

Start from the element and divide by the fraction. At 4.28%, a 5 mg lithium claim needs about 117 mg of lithium orotate; at 18.78%, the same claim needs about 27 mg of lithium carbonate. A 100 mg scoop of the orotate carries about 4.3 mg of lithium, and a 100 mg scoop of the carbonate about 18.8 mg. The 4.4 times factor is the ratio of the two fractions, so it holds at every dose.

That factor moves the whole formula. A 500 mg capsule of orotate delivers about 21.4 mg lithium; the same capsule filled with carbonate would deliver about 94 mg, which is a different product with a different label. Going the other way, a formula built on 27 mg of carbonate does not become a 27 mg orotate formula by swapping the name: it becomes a 117 mg orotate formula, and the capsule, the blend and the label all change with it.

The assay basis is a second conversion that is easy to miss. A 99.0% assay is the purity of the salt, and the lithium figure follows from it: 0.99 × 4.28% is about 4.24% for the orotate, and 0.99 × 18.78% about 18.6% for the carbonate. Neither number is a recommended intake; both are the arithmetic that keeps the label and the weigh-up in agreement.

Handling, solubility and the finished form

The orotate is only slightly soluble, so a stick pack, a drink or a liquid suspension has to be designed as a suspension: a milled grade, a suspending system and a redispersion step. A capsule or tablet avoids the problem: the powder is swallowed with water, and the low solubility does not matter to the fill. Granulation, where it is used, is a flow decision rather than a solubility one.

The carbonate behaves differently in water: it dissolves with an alkaline reaction and releases carbon dioxide when acidified. That is the basis of effervescent tablets, and it is also why a carbonate can disturb an acidic blend, a flavoured drink or a pH-sensitive colour. A formulator who switches salts without rechecking the pH, the taste and the effervescence has changed the product, not just the ingredient.

The orotate is the larger molecule and the more dilute one. In a tablet that needs a sensible weight, that dilution can be an advantage; in a capsule with a fixed size, it sets the ceiling on the lithium figure per capsule. The format decides which arithmetic is workable.

What the label has to say

The ingredient list names the salt, and the declaration gives the quantity in the form the destination requires. Those are two statements about two different masses, and they cannot both be filled in from the same number. A panel that says “lithium” without naming the salt leaves the buyer unable to check the arithmetic; a panel that names the salt without a quantity leaves the reviewer unable to check the dose.

The label must match the drum. A formula written for the carbonate and filled with the orotate is mislabelled even when the powder is genuine and the certificate is clean, because the declared ingredient and the weighed ingredient no longer agree. Either direction is a change control: new specification, new fill weight, new artwork, written approval.

Wording is a separate review. This page makes no disease-related claim and is not a label; the permitted wording, the permitted population and any maximum quantity are decided by the destination's rules, not by the salt.

The route question follows the lithium

In several markets, as of this review, a lithium salt is the active substance of a prescription medicine, and where that is the case a supplement presentation is reviewed against the rules for medicinal substances as well as the rules for foods. That review follows the element and the presentation: the quantity per serving, the claims, the format and the pack. The counter-ion does not settle it. Moving from the carbonate to the orotate changes the mass and the label; it does not convert the substance into an ordinary nutrient, and it does not make a route available that was not available before.

We do not state a regulatory status for either salt in any market. The buyer's regulatory team confirms the route for the destination, in writing, before the salt is fixed; if the confirmed route covers only one presentation, the salt choice cannot rescue it. The route question is worked through on the compliance page, and it should be read before the formulation is frozen.

When each salt is the question

Choose the orotate when the formula needs a larger, more dilute powder mass, when the capsule or tablet format can carry the fill, and when the label is to name lithium orotate. Choose the carbonate when the formula is built around a small, dense, alkaline solid, or when an effervescent system needs it. Neither choice removes the route question, and neither one is a drop-in for the other.

The catalog figures are on the lithium orotate product page; the wider grade picture is on the grades page; the tests that separate the salts are on the identity page; the procedures are in the methods library; release is described on the quality page. We supply the orotate, and the comparison above is a specification argument rather than an offer of both.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation